Carcinoembryonic antigen in patients with urologic cancers

P. Guinan; R. J. Ablin; H. Barakat; T. John; N. Sadoughi; I. M. Bush

doi:10.1007/BF00257371

Carcinoembryonic antigen in patients with urologic cancers

P. Guinan, R. J. Ablin, H. Barakat, T. John, N. Sadoughi, I. M. Bush

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Abstract

101 patients with urologic malignancies were studied for the presence of plasma carcinoembryonic antigen (CEA) employing the radioimmunoassay technique of Hansen. 59% of prostate cancer patients, 76% of bladder cancer patients and 33% of renal cancer patients were CEA positive. There were more positive CEA determinations in patients with higher stage and grade tumors. There were more false positives and false negatives among those patients receiving hormones or radiation.-In summary CEA appears to be present in patients with urologic malignancies. Care should be taken in interpreting CEA results in patients receiving hormones or radiation.

Original language	English (US)
Pages (from-to)	101-105
Number of pages	5
Journal	Urological Research
Volume	1
Issue number	3
DOIs	https://doi.org/10.1007/BF00257371
State	Published - Oct 1973
Externally published	Yes

Keywords

Urologic malignancies
antigens
carcinoembryonic
hormones
radiation
radioimmunoassay

ASJC Scopus subject areas

Urology

Access to Document

10.1007/BF00257371

Cite this

@article{111d9ac1dbe941e5b334eb29e6fa2f41,

title = "Carcinoembryonic antigen in patients with urologic cancers",

abstract = "101 patients with urologic malignancies were studied for the presence of plasma carcinoembryonic antigen (CEA) employing the radioimmunoassay technique of Hansen. 59% of prostate cancer patients, 76% of bladder cancer patients and 33% of renal cancer patients were CEA positive. There were more positive CEA determinations in patients with higher stage and grade tumors. There were more false positives and false negatives among those patients receiving hormones or radiation.-In summary CEA appears to be present in patients with urologic malignancies. Care should be taken in interpreting CEA results in patients receiving hormones or radiation.",

keywords = "Urologic malignancies, antigens, carcinoembryonic, hormones, radiation, radioimmunoassay",

author = "P. Guinan and Ablin, {R. J.} and H. Barakat and T. John and N. Sadoughi and Bush, {I. M.}",

year = "1973",

month = oct,

doi = "10.1007/BF00257371",

language = "English (US)",

volume = "1",

pages = "101--105",

journal = "Urological Research",

issn = "0300-5623",

publisher = "Springer Verlag",

number = "3",

}

TY - JOUR

T1 - Carcinoembryonic antigen in patients with urologic cancers

AU - Guinan, P.

AU - Ablin, R. J.

AU - Barakat, H.

AU - John, T.

AU - Sadoughi, N.

AU - Bush, I. M.

PY - 1973/10

Y1 - 1973/10

N2 - 101 patients with urologic malignancies were studied for the presence of plasma carcinoembryonic antigen (CEA) employing the radioimmunoassay technique of Hansen. 59% of prostate cancer patients, 76% of bladder cancer patients and 33% of renal cancer patients were CEA positive. There were more positive CEA determinations in patients with higher stage and grade tumors. There were more false positives and false negatives among those patients receiving hormones or radiation.-In summary CEA appears to be present in patients with urologic malignancies. Care should be taken in interpreting CEA results in patients receiving hormones or radiation.

AB - 101 patients with urologic malignancies were studied for the presence of plasma carcinoembryonic antigen (CEA) employing the radioimmunoassay technique of Hansen. 59% of prostate cancer patients, 76% of bladder cancer patients and 33% of renal cancer patients were CEA positive. There were more positive CEA determinations in patients with higher stage and grade tumors. There were more false positives and false negatives among those patients receiving hormones or radiation.-In summary CEA appears to be present in patients with urologic malignancies. Care should be taken in interpreting CEA results in patients receiving hormones or radiation.

KW - Urologic malignancies

KW - antigens

KW - carcinoembryonic

KW - hormones

KW - radiation

KW - radioimmunoassay

UR - http://www.scopus.com/inward/record.url?scp=0015887774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015887774&partnerID=8YFLogxK

U2 - 10.1007/BF00257371

DO - 10.1007/BF00257371

M3 - Article

C2 - 4804082

AN - SCOPUS:0015887774

SN - 0300-5623

VL - 1

SP - 101

EP - 105

JO - Urological Research

JF - Urological Research

IS - 3

ER -

Carcinoembryonic antigen in patients with urologic cancers

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this